Free Access
Med Sci (Paris)
Volume 34, October 2018
Cancer biomarkers
Page(s) 87 - 93
Published online 07 November 2018
  1. Epstein JI. Prostate cancer grading: a decade after the 2005 modified system. Modern Pathology An Official Journal of the United States & Canadian Academy of Pathology Inc, 2018;31:S47. [Google Scholar]
  2. Diao K Bian SX Routman DM et al. Combination ipilimumab and radiosurgery for brain metastases: tumor, edema, and adverse radiation effects. Journal of Neurosurgery 2018 ; 1 : [Google Scholar]
  3. Rundle P. Photodynamic Therapy for Eye Cancer. Biomedicines 2017 ; 5 : 69. [Google Scholar]
  4. Epstein JI Prostate cancer grading: a decade after the 2005 modified system. Mod Pathol 2018 ; 31 : S47–S63. [CrossRef] [PubMed] [Google Scholar]
  5. Siegel DA King J Tai E et al. Cancer incidence rates and trends among children and adolescents in the United States, 2001–2009. Pediatrics 2014 ; 134 : e945–e955. [CrossRef] [PubMed] [Google Scholar]
  6. Lee JA Current evidence about the causes of malignant melanoma. Prog Clin Cancer 1975 ; 6 : 151–161. [PubMed] [Google Scholar]
  7. Yu GP Hu DN McCormick SA Latitude and incidence of ocular melanoma. Photochem Photobiol 2006 ; 82 : 1621–1626. [CrossRef] [PubMed] [Google Scholar]
  8. Kanavy HE Gerstenblith MR Ultraviolet radiation and melanoma. Semin Cutan Med Surg 2011 ; 30 : 222–228. [CrossRef] [PubMed] [Google Scholar]
  9. Hu S Ma F Collado-Mesa F Kirsner RS UV radiation, latitude, and melanoma in US Hispanics and blacks. Arch Dermatol 2004 ; 140 : 819–824. [PubMed] [Google Scholar]
  10. Melanoma Treatment (PDQ(R)): Health Professional Version. PDQ Cancer Information Summaries. Bethesda (MD), 2002. [Google Scholar]
  11. Azoury SC, Lange JR. Epidemiology, risk factors, prevention, and early detection of melanoma. Surg Clin North Am 2014;94:945–62, vii. [CrossRef] [PubMed] [Google Scholar]
  12. Syn NL Teng MWL Mok TSK Soo RA De-novo and acquired resistance to immune checkpoint targeting. Lancet Oncol 2017 ; 18 : e731–ee41. [CrossRef] [PubMed] [Google Scholar]
  13. Fiddler IJ Melanoma Metastasis. Cancer Control 1995 ; 2 : 398–404. [CrossRef] [PubMed] [Google Scholar]
  14. Nemeth EF Delmar EG Heaton WL et al. Calcilytic compounds: potent and selective Ca2+ receptor antagonists that stimulate secretion of parathyroid hormone. J Pharmacol Exp Ther 2001 ; 299 : 323–331. [PubMed] [Google Scholar]
  15. Marquis RW Lago AM Callahan JF et al. Antagonists of the calcium receptor I. Amino alcohol-based parathyroid hormone secretagogues. J Med Chem 2009 ; 52 : 3982–3993. [CrossRef] [PubMed] [Google Scholar]
  16. Kiefer L Leiris S Dodd RH Novel calcium sensing receptor ligands: a patent survey. Expert Opin Ther Pat 2011 ; 21 : 681–698. [CrossRef] [Google Scholar]
  17. Breitwieser GE Pharmacoperones and the calcium sensing receptor: exogenous and endogenous regulators. Pharmacol Res 2014 ; 83 : 30–37. [CrossRef] [PubMed] [Google Scholar]
  18. Gowen M Stroup GB Dodds RA et al. Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats. J Clin Invest 2000 ; 105 : 1595–1604. [CrossRef] [PubMed] [Google Scholar]
  19. Gross A McDonnell JM Korsmeyer SJ BCL-2 family members and the mitochondria in apoptosis. Genes Dev 1999 ; 13 : 1899–1911. [CrossRef] [PubMed] [Google Scholar]
  20. Martinou JC Youle RJ Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell 2011 ; 21 : 92–101. [CrossRef] [PubMed] [Google Scholar]
  21. Norata GD Tonti L Roma P Catapano AL Apoptosis and proliferation of endothelial cells in early atherosclerotic lesions: possible role of oxidised LDL. Nutr Metab Cardiovasc Dis 2002 ; 12 : 297–305. [PubMed] [Google Scholar]
  22. Rameh LE Cantley LC The role of phosphoinositide 3-kinase lipid products in cell function. J Biol Chem 1999 ; 274 : 8347–8350. [CrossRef] [PubMed] [Google Scholar]
  23. Downward J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 1998 ; 10 : 262–267. [CrossRef] [PubMed] [Google Scholar]
  24. Shaw RJ Cantley LC Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 2006 ; 441 : 424–430. [CrossRef] [PubMed] [Google Scholar]
  25. Raught B Gingras AC Sonenberg N The target of rapamycin (TOR) proteins. Proc Natl Acad Sci USA 2001 ; 98 : 7037–7044. [CrossRef] [Google Scholar]
  26. Jefferies HB Fumagalli S Dennis PB et al. Rapamycin suppresses 5’TOP mRNA translation through inhibition of p70s6k. EMBO J 1997 ; 16 : 3693–3704. [CrossRef] [PubMed] [Google Scholar]
  27. Li DM Song WW Wang Y Fu JL The investigations on the relationship between the birth weight of fetus and the P70 S6K as well as mechanism insulin regulate the birth weight of fetus. Zhonghua Yi Xue Za Zhi 2009 ; 89 : 2924–2927. [PubMed] [Google Scholar]
  28. Disease GBD Injury I Prevalence C Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016 ; 388 : 1545–1602. [CrossRef] [PubMed] [Google Scholar]
  29. Mortality GBD Causes of Death C. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016 ; 388 : 1459–1544. [CrossRef] [PubMed] [Google Scholar]
  30. Eskes R Antonsson B Osen-Sand A et al. Bax-induced cytochrome C release from mitochondria is independent of the permeability transition pore but highly dependent on Mg2+ ions. J Cell Biol 1998 ; 143 : 217–224. [CrossRef] [PubMed] [Google Scholar]
  31. Wang Z Wang N Han S et al. Dietary compound isoliquiritigenin inhibits breast cancer neoangiogenesis via VEGF/VEGFR-2 signaling pathway. PLoS One 2013 ; 8 : e68566. [CrossRef] [PubMed] [Google Scholar]
  32. Stal O Perez-Tenorio G Akerberg L et al. Akt kinases in breast cancer and the results of adjuvant therapy. Breast Cancer Res 2003 ; 5 : R37–R44. [CrossRef] [PubMed] [Google Scholar]
  33. Brown EJ Albers MW Shin TB et al. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 1994 ; 369 : 756–758. [CrossRef] [PubMed] [Google Scholar]
  34. Ersahin T Tuncbag N Cetin-Atalay R The PI3K/AKT/mTOR interactive pathway. Mol Biosyst 2015 ; 11 : 1946–1954. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.